Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Northwestern University, Feingberg School of Medicine, Chicago, Illinois, United States
Severance Hospital, Seoul, Korea, Republic of
Centre Léon Bérard, LYON Cedex 08, France
Lifecenter Hospital, Belo Horizonte, Minas Gerais, Brazil
Odense University Hospital, Odense, DK, Denmark
Hospices Civils de Lyon, Hopital Louis Pradel, Department of Anesthesiology, Bron, France
Departement d'Anesthesie-Reanimation, Hopital Saint-Antoine, Paris, France
Anesthesiology Service of Univeritary Hospital of Bellvitge, Hospitalet . Barcelona, Barcelona, Spain
Piracicaba Dental School, Piracicaba, Sao Paulo, Brazil
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.